Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice

Blood. 2012 Mar 1;119(9):2176-7. doi: 10.1182/blood-2011-10-388892.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Fingolimod Hydrochloride
  • Immunologic Surveillance / drug effects*
  • Immunosuppressive Agents / pharmacology*
  • Lymphoma, B-Cell / immunology*
  • Mice
  • Mice, SCID
  • Mice, Transgenic
  • Multiple Myeloma / immunology*
  • Propylene Glycols / pharmacology*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine